DSpace コレクション: 1992-02
http://hdl.handle.net/10564/1921
1992-022024-03-29T10:01:23Z奈良県立医科大学泌尿器科学教室における1989年の臨床統計
http://hdl.handle.net/10564/1933
タイトル: 奈良県立医科大学泌尿器科学教室における1989年の臨床統計
著者: 平山, 暁秀; 岡島, 英五郎; 平尾, 佳彦; 大園, 誠一郎; 三馬, 省二; 金子, 佳照; 佐々木, 憲二; 松木, 尚; 守屋, 昭; 岩井, 哲郎; 中辻, 史好; 植村, 天受; 田畑, 尚一; 藤本, 清秀; 辻本, 賀洋; 丘田, 英人; 吉井, 将人; 山田, 一; 大山, 信雄; 河田, 陽一; 田中, 宣道; 福井, 義尚; 安川, 元信
抄録: Clinical statistics in 1989 on outpatients, inpatients and operations in the Department of Urology, Nara Medical University, are reported in this paper. The total number of outpatients was 3,988, and inpatients numbered 371. Among these inpatients, urological tumors were most frequent (148 cases, 37.8%), followed by urolithiasis (111
cases, 28.4%), renal failure (58 cases, 15.6%), and others. Totally 464 operations were performed for these inpatients.1992-02-28T15:00:00ZSilver methenamine and Masson's trichrome重染色による腎糸球体の観察(基底膜変化を中心に)
http://hdl.handle.net/10564/1932
タイトル: Silver methenamine and Masson's trichrome重染色による腎糸球体の観察(基底膜変化を中心に)
著者: 岡島, 馨; 山下, 隆司; 松永, 健司; 河原, 信吾; 中島, 充; 平, 康二; 上辻, 秀和
抄録: In order to observe the precise morphological changes of glomeruli on light
microscopic level, silver methenamine and Masson's trichrome (SM-MT) staining was employed on renal biopsy sections from children with various glomerular diseases. With the SM-MT staining, basement membrane stains black, red blood cells red, fresh
fibrinoid material bright red and protein deposits are stained red in various shades depending on the composition and age of the deposits. There was a good contrast between
basement membrane and other materials. These light microscopic changes reflected well the ultrastructural changes which were investigated simultaneously in several cases.
Therefore, it is suggested that this staining provides valuable information about glomerular changes on routine light microscopy.1992-02-28T15:00:00Z消化性潰瘍の維持療法に関する臨床的検討
http://hdl.handle.net/10564/1931
タイトル: 消化性潰瘍の維持療法に関する臨床的検討
著者: 吉本, 正伸
抄録: Two hundred-forty-nine gastric ulcer (GU) patients and 113 duodenal ulcer (DU) patients found in a gastric mass survey were available for this study. A combination regimen of H₂ blocker and mucosal-protective agents was administered in the
initial treatment and maintenance therapy (MT). During maintenance therapy, after S₁
scar (red scar) and S₂ scar (white scar) had been confirmed, S₂ healing rate and shifting rate from S₁ to S₂ were calculated. On the other hand, in case of recurrence of ulcer, recurrence rate was calculated. After maintenance therapy, recurrence rates were compared with the scar stage at the end of MT and the length of MT. Results : S₁ healing rate was 84.0% (3 M) in GU and 83.2% (3 M) in DU and the shifting rate from S₁ to S₂ was 63.8% (3 M), 82.3% (6 M) in GU and 65.6% (3 M), 89.2% (6 M) in DU. Recurrence rate from S₁ was 35% (3 M) and 70% (6 M) in GU, almost the same pattern as DU. Shifting rate from S₁ to S₂ in maintenance therapy was significantly lower in intractable ulcer than easily healing ulcer in GU and DU. Recurrence rate after long-term maintenance therapy was significantly lower than that of short term in GU and DU. Recurrence rate from S₁ was significantly higher than that of S₂ in intractable GU. In long-term MT and S₂ at the end of MT, the recurrence rate was relatively low in intractable DU. Conclusion : At least 6 months and sufficiently 12 months MT was nessesary to confirm S₂. In the prevention of recurrence after MT, long-term MT was more effective than short-term and it was necessary that S₂ should be confirmed at the end of MT in intractable GU and DU. In early relapsing ulcer from S₁ at the early period of MT, it was considered that half the therapeutic dose of H₂ blocker was insufficient.1992-02-28T15:00:00ZTHE EXPRESSION OF THE fms GENE AND THE GENE PRODUCT IN THYROID TUMOR
http://hdl.handle.net/10564/1930
タイトル: THE EXPRESSION OF THE fms GENE AND THE GENE PRODUCT IN THYROID TUMOR
著者: Haga, Satomi; Inui, Masahiko; Matsuzuka, Humio; Katayama, Shouichi; Yamamoto, Hiroshi; Hiasa, Yoshio
抄録: The amplification of the fms gene DNA was investigated in 5 human thyroid tumors. No significant amplification or rearrangement was observed in tumor DNA. The expression of the fms gene product was also investigated in 20 thyroid tumor tissues embedded in paraffin using a polyclonal antibody to the fms oncogene product immunohistochemically. Ten out of 20 samples showed clearly positive, 6 out of 20 were weakly positive but 4 out of 20 were negative. Therefore, the fms oncogene might play an
important role for thyroid carcinogenesis, and it might also be of possible importance for understanding the mechanism of thyroid carcinogenesis.1992-02-28T15:00:00Z